This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:37, 10 January 2012 (Saving copy of the {{drugbox}} taken from revid 469151562 of page Ustekinumab for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:37, 10 January 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 469151562 of page Ustekinumab for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This page contains a copy of the infobox ({{drugbox}}) taken from revid 469151562 of page Ustekinumab with values updated to verified values. |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | IL-12 and IL-23 |
| Clinical data | |
| Trade names | Stelara |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a611013 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | subcutaneous injection |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6482H10004N1712O2016S46 |
| Molar mass | 145.64 kDa g·mol |
| (what is this?) (verify) | |
